Loading clinical trials...
Loading clinical trials...
A Multicenter, Open-label Extension Trial to Evaluate the Efficacy, Safety and Tolerability of HZN-825 in Patients With Diffuse Cutaneous Systemic Sclerosis
Conditions
Interventions
HZN-825
Locations
65
United States
Arizona Arthritis and Rheumatology Associates -4550 E Bell Rd
Phoenix, Arizona, United States
UCLA Medical Center
Los Angeles, California, United States
University of Miami Miller School of Medicine
Miami, Florida, United States
IRIS Research and Development LLC
Plantation, Florida, United States
DelRicht Clinical Research, LLC - Internal - Covington - PPDS
New Orleans, Louisiana, United States
Boston University School Of Medicine
Boston, Massachusetts, United States
Start Date
November 4, 2022
Primary Completion Date
February 24, 2025
Completion Date
February 24, 2025
Last Updated
January 5, 2026
NCT04356287
NCT05270668
NCT04986605
NCT04478994
NCT03198689
NCT04138485
Lead Sponsor
Amgen
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions